BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33213771)

  • 41. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
    Berger BM; Schroy PC; Dinh TA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
    Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
    Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal age for screening colonoscopy: a modeling study.
    Chen C; Stock C; Hoffmeister M; Brenner H
    Gastrointest Endosc; 2019 May; 89(5):1017-1025.e12. PubMed ID: 30639539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An updated review of the methods, guidelines of, and controversies on screening for colorectal cancer.
    Emile SH; Barsom SH; Wexner SD
    Am J Surg; 2022 Jul; 224(1 Pt B):339-347. PubMed ID: 35367029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
    Hassan C; Rex DK; Zullo A; Cooper GS
    Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current status of screening for colorectal cancer.
    Garborg K; Holme Ø; Løberg M; Kalager M; Adami HO; Bretthauer M
    Ann Oncol; 2013 Aug; 24(8):1963-72. PubMed ID: 23619033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Am J Gastroenterol; 2017 Jul; 112(7):1016-1030. PubMed ID: 28555630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
    Ladabaum U; Mannalithara A; Mitani A; Desai M
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
    Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.
    Schroy PC; Wong JB; O'Brien MJ; Chen CA; Griffith JL
    Am J Gastroenterol; 2015 Jul; 110(7):1062-71. PubMed ID: 26010311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
    Buchman S; Rozmovits L; Glazier RH
    Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test?
    Hamarneh Z; Symonds EL; Kholmurodova F; Cock C
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1002-1008. PubMed ID: 31606908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colorectal Cancer Screening in Average Risk Populations: Evidence Summary.
    Tinmouth J; Vella ET; Baxter NN; Dubé C; Gould M; Hey A; Ismaila N; McCurdy BR; Paszat L
    Can J Gastroenterol Hepatol; 2016; 2016():2878149. PubMed ID: 27597935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colon cancer screening. Sigmoidoscopy or colonoscopy.
    Khullar SK; DiSario JA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):365-86. PubMed ID: 9177140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal cancer screening: a global overview of existing programmes.
    Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
    Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colonoscopy screening among US adults aged 40 or older with a family history of colorectal cancer.
    Tsai MH; Xirasagar S; Li YJ; de Groen PC
    Prev Chronic Dis; 2015 May; 12():E80. PubMed ID: 25996988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colorectal cancer screening: An updated review of the available options.
    Issa IA; Noureddine M
    World J Gastroenterol; 2017 Jul; 23(28):5086-5096. PubMed ID: 28811705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Why is early detection of colon cancer still not possible in 2023?
    Tonini V; Zanni M
    World J Gastroenterol; 2024 Jan; 30(3):211-224. PubMed ID: 38314134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.